首页> 美国卫生研究院文献>ACS AuthorChoice >Impact of TargetWarhead and Linkage Vector on InducingProtein Degradation: Comparison of Bromodomain and Extra-Terminal(BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline(I-BET726) BET Inhibitor Scaffolds
【2h】

Impact of TargetWarhead and Linkage Vector on InducingProtein Degradation: Comparison of Bromodomain and Extra-Terminal(BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline(I-BET726) BET Inhibitor Scaffolds

机译:目标的影响诱导上的战斗部和连杆矢量蛋白质降解:溴结构域和末端的比较(BET)源自三唑并二氮杂(JQ1)和四氢喹啉的降解剂(I-BET726)BET抑制剂支架

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The design of proteolysis-targeting chimeras (PROTACs) is a powerful small-molecule approach for inducing protein degradation. PROTACs conjugate a target warhead to an E3 ubiquitin ligase ligand via a linker. Here we examined the impact of derivatizing two different BET bromodomain inhibitors, triazolodiazepine JQ1 and the more potent tetrahydroquinoline I-BET726, via distinct exit vectors, using different polyethylene glycol linkers to VHL ligand VH032. Triazolodiazepine PROTACs exhibited positive cooperativities of ternary complex formation and were more potent degraders than tetrahydroquinoline compounds, which showed negative cooperativities instead. Marked dependency on linker length was observed for BET-degrading and cMyc-driven antiproliferative activities in acute myeloid leukemia cell lines. This work exemplifies as a cautionary tale how a more potent inhibitor does not necessarily generate more potent PROTACs and underscores the key roles played by the conjugation. The provided insights and framework for structure–activity relationships of bivalent degraders are anticipated to have wide futureapplicability.
机译:靶向蛋白水解嵌合体(PROTAC)的设计是一种强大的小分子方法,可诱导蛋白质降解。 PROTAC通过接头将靶标战斗部与E3泛素连接酶配体缀合。在这里,我们使用不同的聚乙二醇接头连接VHL配体VH032,通过不同的退出载体检查了两种不同的BET溴结构域抑制剂三唑二氮杂品JQ1和更有效的四氢喹啉I-BET726的衍生作用。与四氢喹啉化合物相比,三唑并二氮杂PROPROTAC显示出三元络合物形成的正合作性,并且是更有效的降解剂,而四氢喹啉化合物则显示出负的合作性。在急性髓样白血病细胞系中观察到对BET降解和cMyc驱动的抗增殖活性明显依赖于接头长度。这项工作作为一个警示性事例,说明了如何使用更有效的抑制剂不一定能产生更有效的PROTAC,并强调了缀合物所起的关键作用。为二价降解物的结构-活性关系提供的见解和框架预期具有广阔的前景适用性。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号